🔓
Sign in as a Member to unlock the full view of HRES.1081. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
HRES.1081 · 119TH CONGRESS

Raising awareness for the sarcoma cancer chordoma.

Status
In Committee
Latest Action
2026-02-25
Sponsor
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
1
Full Text
1,768 chars
Alive
Yes

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Action Timeline

2026-02-25
Referred to the House Committee on Energy and Commerce.
2026-02-25
Submitted in House
2026-02-25
Submitted in House

Frequently Asked Questions

Did HRES.1081 pass?
HRES.1081 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HRES.1081?
HRES.1081 was sponsored by Henry C. "Hank" Johnson (D-Georgia).

Full Bill Text

119 HRES 1081 IH: Raising awareness for the sarcoma cancer chordoma. U.S. House of Representatives 2026-02-25 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IV 119th CONGRESS 2d Session H. RES. 1081 IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Johnson of Georgia submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Raising awareness for the sarcoma cancer chordoma. Whereas chordoma is a slow growing, yet aggressive bone cancer of the skull and spine; Whereas it strikes people of all ages and affects more than 25,000 individuals worldwide; Whereas, each year, thousands of people are diagnosed with chordoma including about 300 people annually in the United States; Whereas chordomas are among the most complicated tumors to treat due to involvement of critical structures such as the brain stem, spinal cord, and important nerves and arteries; Whereas surgery or radiation performed by a skilled treatment team can be curative for some patients, but even with the best care possible, the recurrence rate remains high; and Whereas no drugs are known to cure or effectively control the disease, meaning that patients whose disease progresses after exhausting surgical and radiation options have little hope for a full recovery: Now, therefore, be it That it is the sense of the House of Representatives that chordoma patients and families need increased funding and support for— (1) accurate and early diagnosis; (2) the development of new treatments, diagnostics, and cures; (3) fewer hurdles between research and new treatments; and (4) patient-centric approaches to drug discovery and development.
🔒 GovGreed Pro · Trading Intelligence on HRES.1081 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-08-28. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]